Share-Based Payments (Tables)

6 Months Ended

Jun. 30, 2020

The following table summarizes share-based compensation expense included in our condensed consolidated statements of income:



	For the Three Months Ended June 30,						For the Six Months Ended June 30,
(In millions)	2020			2019			2020			2019
Research and development	$	15.2		$	28.1		$	48.5		$	49.8
Selling, general and administrative	30.3			54.8			73.4			82.6
Subtotal	45.5			82.9			121.9			132.4
Capitalized share-based compensation costs	(1.5		)	(2.8		)	(3.0		)	(6.1		)
Share-based compensation expense included in total cost and expenses	44.0			80.1			118.9			126.3
Income tax effect	(7.0		)	(13.6		)	(20.3		)	(21.0		)
Share-based compensation expense included in net income attributable to Biogen Inc.	$	37.0		$	66.5		$	98.6		$	105.3

The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:



	For the Three Months Ended June 30,						For the Six Months Ended June 30,
(In millions)	2020			2019			2020			2019
Market stock units	$	7.4		$	7.8		$	26.5		$	15.5
Time-vested restricted stock units	34.5			31.8			72.0			66.5
Cash settled performance units	(0.1		)	0.4			(1.7		)	(0.6		)
Performance units	—			0.3			(0.1		)	0.8
Performance stock units settled in stock	2.1			12.1			12.4			14.1
Performance stock units settled in cash	(4.0		)	0.9			4.9			1.9
Employee stock purchase plan	5.6			3.4			7.9			8.0
NST stock options	—			26.2			—			26.2
Subtotal	45.5			82.9			121.9			132.4
Capitalized share-based compensation costs	(1.5		)	(2.8		)	(3.0		)	(6.1		)
Share-based compensation expense included in total cost and expenses	$	44.0		$	80.1		$	118.9		$	126.3